English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Ten patients received 2000 mg of ceftazidime intravenously before undergoing lower-extremity amputation for ischaemia. Bone and plasma concentrations were determined by HPLC. The bone concentrations were corrected for blood contamination. In all but one sample ceftazidime was detectable. The median concentration in the midfoot, 4.8 microg/g (range 1.2-11.4 microg/g), was higher than the median concentration in the forefoot, 3.1 microg/g (range 0.8-15.7 microg/g) (P &lt;0.05). In the majority (&gt;90%) of bone samples taken from sites with gangrenous skin the ceftazidime concentration was &gt;1.8 mg/kg bone. The present data indicate that ceftazidime penetrates into bone of severely ischaemic limbs.

Penetration of ceftazidime into bone from severely ischaemic limbs